About
Nano-engineered treatments
Areas of Focus
Categories
NanotechBoston & New England
Team (9)
Albert Collinson
Albert Collinson, PH.D
Privo Technologies
team_member
Cuthbert Thomas
Cuthbert Thomas, CPA/ABV, CGMA
Privo Technologies
team_member
Cuthbert Thomas
Cuthbert Thomas, CPA/ABV, CGMA
Privo Technologies
team_member
James Mackay
James Mackay, PH.D
Privo Technologies
team_member
Jane Hirsh
Jane Hirsh
Privo Technologies
team_member
Manijeh Goldberg
Manijeh Goldberg, PH.D., M.B.A., M.S.
Privo Technologies
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
50
By Phase
PHASE2/PHASE3: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05893888Lead Sponsor
Safety and Efficacy Study of PRV111 and PRV211 in Subjects With Oral Squamous Cell Carcinoma
PHASE2/PHASE3Recruiting
40 participants
Started: Nov 7, 2024 · Completed: May 31, 2027
NCT03502148Lead Sponsor
Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma
PHASE1/PHASE2Completed
10 participants
Started: Jun 19, 2018 · Completed: May 6, 2020
Locations (1)
Headquarters
Peabody, MA, United States
Map
Loading map...